Skip to content

Is Dextroamphetamine recalled?

48 FDA recalls mention Dextroamphetamine. The most recent are listed below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Dextroamphetamine.

Class II · Moderate risk Terminated Aug 24, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets…

Reason Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Amerisource Health Services NDC 60687-154-25 D-1485-2016

Class II · Moderate risk Terminated Aug 24, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets…

Reason Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Amerisource Health Services NDC 68084-943-25 D-1484-2016

Class II · Moderate risk Terminated Aug 24, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets…

Reason Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Amerisource Health Services NDC 60687-133-25 D-1483-2016

Class II · Moderate risk Terminated Aug 24, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets…

Reason Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Amerisource Health Services NDC 68084-936-25 D-1482-2016

Class II · Moderate risk Terminated Aug 24, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets…

Reason Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Amerisource Health Services NDC 68084-874-25 D-1481-2016

Class II · Moderate risk Terminated Jul 11, 2016

Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC…

Reason Failed Dissolution Specifications

Actavis Inc NDC 45963-304-09 D-1448-2016

Class II · Moderate risk Terminated Mar 14, 2016

Dextroamphetamine Sulfate Tablets USP, 5 mg, 100-count bottle, Rx only, Manufactured and Distributed by: CorePharma, LLC…

Reason Failed Impurities/Degradation Specifications

Impax Laboratories, Inc. NDC 64720-215-10 D-0826-2016

Class II · Moderate risk Terminated Mar 14, 2016

Dextroamphetamine Sulfate Tablets USP, 10 mg, 100-count bottle, Rx only, Manufactured and Distributed by: Corepharma, LLC…

Reason Failed Impurities/Degradation Specifications

Impax Laboratories, Inc. NDC 64720-0216-10 D-0825-2016

Class II · Moderate risk Terminated Feb 16, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 5 mg, 100 ct…

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Actavis Elizabeth LLC D-0816-2016

Class II · Moderate risk Terminated Feb 16, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 30 mg, 100 ct…

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Actavis Elizabeth LLC D-0815-2016

Class II · Moderate risk Terminated Feb 16, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 20 mg, 100 ct…

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Actavis Elizabeth LLC D-0814-2016

Class II · Moderate risk Terminated Feb 16, 2016

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 10 mg, 100 ct…

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Actavis Elizabeth LLC D-0813-2016

Class II · Moderate risk Terminated Nov 12, 2015

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a…

Reason Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

Teva Pharmaceuticals USA NDC 0555-0972-02 D-0566-2016

Class II · Moderate risk Terminated Jun 24, 2015

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, (CII), 10 mg…

Reason Failed Impurities/Degradation Specifications: out of specification for unknown impurity

Teva Pharmaceuticals USA NDC 0555-0972-02 D-1283-2015

Class II · Moderate risk Terminated Feb 10, 2015

Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC…

Reason Failed Dissolution Specifications

Actavis Elizabeth LLC NDC 45963-305-09 D-0395-2015

Class II · Moderate risk Terminated Oct 8, 2014

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets, (CII), 10 mg, 100…

Reason Failed Impurities/Degradation Specifications: Out of specification for unknown impurities.

Teva Pharmaceuticals USA D-0050-2015

Class II · Moderate risk Terminated May 1, 2014

Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC…

Reason Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during…

Teva Pharmaceuticals USA NDC 0555-0953-02 D-1408-2014

Class II · Moderate risk Terminated Jan 24, 2014

Teva Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg…

Reason CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg were…

Teva Pharmaceuticals USA NDC 0555-0972-02 D-1094-2014

Class II · Moderate risk Terminated Oct 7, 2013

Dexedrine¿ (Dextroamphetamine Sulfate) Spansules¿ Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by…

Reason Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.

Amedra Pharmaceuticals LLC NDC 52054-514-09 D-385-2014

Class III · Low risk Terminated Feb 13, 2013

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release…

Reason Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications. All other test…

Actavis Elizabeth LLC NDC 0228-3063-11 D-190-2013

Class II · Moderate risk Terminated Dec 4, 2012

Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for…

Reason Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

Amedra Pharmaceuticals LLC NDC 64720-329-09 D-173-2013

Class II · Moderate risk Terminated Dec 4, 2012

Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for…

Reason Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

Amedra Pharmaceuticals LLC NDC 64720-328-09 D-172-2013

Class II · Moderate risk Terminated Dec 4, 2012

Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for…

Reason Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

Amedra Pharmaceuticals LLC NDC 64720-327-09 D-171-2013